CYCC
Price
$13.07
Change
+$4.84 (+58.81%)
Updated
Jul 18 closing price
Capitalization
20.7M
JSPR
Price
$3.33
Change
-$0.04 (-1.19%)
Updated
Jul 18 closing price
Capitalization
50.02M
Interact to see
Advertisement

CYCC vs JSPR

Header iconCYCC vs JSPR Comparison
Open Charts CYCC vs JSPRBanner chart's image
Cyclacel Pharmaceuticals
Price$13.07
Change+$4.84 (+58.81%)
Volume$22.37M
Capitalization20.7M
Jasper Therapeutics
Price$3.33
Change-$0.04 (-1.19%)
Volume$350.33K
Capitalization50.02M
CYCC vs JSPR Comparison Chart in %
Loading...
CYCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYCC vs. JSPR commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYCC is a Hold and JSPR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (CYCC: $13.07 vs. JSPR: $3.33)
Brand notoriety: CYCC and JSPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYCC: 543% vs. JSPR: 46%
Market capitalization -- CYCC: $20.7M vs. JSPR: $50.02M
CYCC [@Biotechnology] is valued at $20.7M. JSPR’s [@Biotechnology] market capitalization is $50.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYCC’s FA Score shows that 0 FA rating(s) are green whileJSPR’s FA Score has 2 green FA rating(s).

  • CYCC’s FA Score: 0 green, 5 red.
  • JSPR’s FA Score: 2 green, 3 red.
According to our system of comparison, JSPR is a better buy in the long-term than CYCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYCC’s TA Score shows that 4 TA indicator(s) are bullish while JSPR’s TA Score has 5 bullish TA indicator(s).

  • CYCC’s TA Score: 4 bullish, 4 bearish.
  • JSPR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both CYCC and JSPR are a good buy in the short-term.

Price Growth

CYCC (@Biotechnology) experienced а +252.29% price change this week, while JSPR (@Biotechnology) price change was -5.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JSPR($50M) has a higher market cap than CYCC($20.7M). JSPR (-84.425) and CYCC (-85.516) have similar YTD gains . JSPR has more cash in the bank: 48.8M vs. CYCC (93K). CYCC has less debt than JSPR: CYCC (9K) vs JSPR (2.59M).
CYCCJSPRCYCC / JSPR
Capitalization20.7M50M41%
EBITDAN/A-81.61M-
Gain YTD-85.516-84.425101%
P/E Ratio0.30N/A-
RevenueN/A0-
Total Cash93K48.8M0%
Total Debt9K2.59M0%
FUNDAMENTALS RATINGS
CYCC: Fundamental Ratings
CYCC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYCCJSPR
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
66%
Momentum
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
71%
MACD
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
66%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
75%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 5 days ago
73%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 7 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
70%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 6 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
CYCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRC51.263.23
+6.72%
California Resources Corp
EA150.110.28
+0.19%
Electronic Arts
EPRX5.29-0.12
-2.17%
Eupraxia Pharmaceuticals
IPDN2.51-0.06
-2.33%
Professional Diversity Network Inc
CTKB3.13-0.17
-5.15%
Cytek Biosciences

CYCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYCC has been loosely correlated with PROK. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CYCC jumps, then PROK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYCC
1D Price
Change %
CYCC100%
+58.81%
PROK - CYCC
57%
Loosely correlated
-10.51%
JSPR - CYCC
36%
Loosely correlated
-1.19%
MTVA - CYCC
26%
Poorly correlated
+0.43%
HOWL - CYCC
24%
Poorly correlated
+0.71%
RLYB - CYCC
22%
Poorly correlated
-5.43%
More

JSPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, JSPR has been loosely correlated with AVXL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if JSPR jumps, then AVXL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JSPR
1D Price
Change %
JSPR100%
-1.19%
AVXL - JSPR
38%
Loosely correlated
-0.72%
APGE - JSPR
38%
Loosely correlated
+0.79%
DSGN - JSPR
36%
Loosely correlated
-1.00%
CYCC - JSPR
36%
Loosely correlated
+58.81%
PDSB - JSPR
34%
Loosely correlated
-4.17%
More